NEW YORK and LONDON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced …
[Read more...] about Akari Therapeutics to Present at Biotech Showcase 2023
Check out the discussion transcript from The Science Huddle: Small Data Big Outcomes
CLICK TO READ ENTIRE TRANSCRIPT With the reach and impact of biopharma growing exponentially, experts in biotech and the evolving regulatory environment came …
Akari Therapeutics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology, and Medtech/ Diagnostic Conference
NEW YORK and LONDON, December 1, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced …
Akari on the Business of Biotech podcast
Ticks aren’t all bad! Check out the Business of Biotech podcast to hear how Akari engineered #nomacopan, a recombinant protein derived from ticks, and scaled …
[Read more...] about Akari on the Business of Biotech podcast
Akari Therapeutics to Participate in the Ophthalmology Day at BTIG
NEW YORK and LONDON, November 22, 2022(GLOBE NEWSWIRE) - Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced …
[Read more...] about Akari Therapeutics to Participate in the Ophthalmology Day at BTIG
